Chesterfield, MO, United States of America

Nicholaos K Hrakas

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholaos K Hrakas. Retrieved from https://idiyas.com/inventor/nicholaos-k-hrakas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicholaos K Hrakas

Introduction

Nicholaos K Hrakas is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical research and therapeutic applications.

Latest Patents

Hrakas holds a patent for a monoclonal antibody specific for human colon fibroblast-derived tissue plasminogen activator (t-PA). This invention is crucial for immunoaffinity chromatography purification of t-PA and for determining t-PA levels in biological samples. The patent highlights his innovative approach to addressing challenges in the field of biochemistry.

Career Highlights

Hrakas is associated with Monsanto Company, where he has contributed to various research initiatives. His expertise in monoclonal antibodies has positioned him as a valuable asset in the biotechnology sector. His work continues to influence advancements in medical diagnostics and treatment.

Collaborations

Hrakas has collaborated with notable colleagues, including Jon P Schaumann and Jitka V Olander. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Nicholaos K Hrakas exemplifies the spirit of innovation in biotechnology through his patent and contributions at Monsanto Company. His work on monoclonal antibodies is paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…